tiprankstipranks
CERo Therapeutics Holdings (CERO)
NASDAQ:CERO
US Market

CERo Therapeutics Holdings (CERO) Income Statement

Compare
375 Followers

CERo Therapeutics Holdings Income Statement

Last quarter (Q3 2024), CERo Therapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, CERo Therapeutics Holdings's net income was $-4.23M. See CERo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 2.93M$ 2.91M$ 332.03K
Depreciation and Amortization
-$ 1.07M$ 735.47K
EBITDA
$ -2.44M$ -68.58K$ -332.03K
Operating Income
$ -2.93M$ -2.91M$ -332.03K
Other Income/Expenses
$ 491.57K$ 2.84M$ 99.08K
Pretax Income
$ -2.44M$ -68.58K$ -332.42K
Net Income
-$ -667.74K$ -315.55K
Per Share Metrics
Basic EPS
$ -0.39$ -0.10$ -0.01
Diluted EPS
$ -0.39$ -0.10$ -0.01
Weighted Average Shares Outstanding
6.53M 6.77M 22.98M
Weighted Average Shares Outstanding (Diluted)
6.53M 6.77M 22.98M
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis